REPLIGEN CORP's ticker is RGEN and the CUSIP is 759916109. A total of 197 filers reported holding REPLIGEN CORP in Q3 2017. The put-call ratio across all filers is 1.52 and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q2 2020 | $179,000 | +27.9% | 1,450 | 0.0% | 0.01% | +25.0% |
| Q1 2020 | $140,000 | +26.1% | 1,450 | 0.0% | 0.00% | +33.3% |
| Q3 2019 | $111,000 | -11.2% | 1,450 | 0.0% | 0.00% | -40.0% |
| Q2 2019 | $125,000 | +45.3% | 1,450 | 0.0% | 0.01% | +66.7% |
| Q1 2019 | $86,000 | +13.2% | 1,450 | 0.0% | 0.00% | 0.0% |
| Q4 2018 | $76,000 | -5.0% | 1,450 | 0.0% | 0.00% | 0.0% |
| Q3 2018 | $80,000 | +17.6% | 1,450 | 0.0% | 0.00% | 0.0% |
| Q2 2018 | $68,000 | +30.8% | 1,450 | 0.0% | 0.00% | +50.0% |
| Q1 2018 | $52,000 | -1.9% | 1,450 | 0.0% | 0.00% | 0.0% |
| Q4 2017 | $53,000 | -5.4% | 1,450 | 0.0% | 0.00% | 0.0% |
| Q3 2017 | $56,000 | -6.7% | 1,450 | 0.0% | 0.00% | -33.3% |
| Q2 2017 | $60,000 | +17.6% | 1,450 | 0.0% | 0.00% | +50.0% |
| Q1 2017 | $51,000 | – | 1,450 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| 12 West Capital Management LP | 1,021,641 | $295,244,000 | 13.47% |
| Ally Bridge Group (NY) LLC | 70,000 | $20,229,000 | 5.95% |
| Miura Global Management | 85,000 | $24,564,000 | 3.81% |
| Conestoga Capital Advisors, LLC | 871,390 | $251,823,000 | 3.48% |
| Ranger Investment Management | 187,723 | $54,250,000 | 2.90% |
| AWM Investment Company, Inc. | 100,000 | $28,899,000 | 2.84% |
| Brown Capital Management | 1,017,477 | $294,041,000 | 2.41% |
| Stephens Investment Management Group LLC | 558,287 | $161,339,000 | 2.19% |
| Yorktown Management & Research Co Inc | 10,050 | $2,904,000 | 2.18% |
| SV Health Investors, LLC | 14,541 | $4,203,000 | 2.06% |